DB-1419
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DB-1419, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]